Jian‐Li Jiang

6.5k total citations · 1 hit paper
91 papers, 3.7k citations indexed

About

Jian‐Li Jiang is a scholar working on Molecular Biology, Immunology and Oncology. According to data from OpenAlex, Jian‐Li Jiang has authored 91 papers receiving a total of 3.7k indexed citations (citations by other indexed papers that have themselves been cited), including 65 papers in Molecular Biology, 25 papers in Immunology and 15 papers in Oncology. Recurrent topics in Jian‐Li Jiang's work include Signaling Pathways in Disease (46 papers), Galectins and Cancer Biology (17 papers) and Cell Adhesion Molecules Research (10 papers). Jian‐Li Jiang is often cited by papers focused on Signaling Pathways in Disease (46 papers), Galectins and Cancer Biology (17 papers) and Cell Adhesion Molecules Research (10 papers). Jian‐Li Jiang collaborates with scholars based in China, United States and Hong Kong. Jian‐Li Jiang's co-authors include Zhi‐Nan Chen, Juan Tang, Yunshan Guo, Meirui Qian, Yiming Li, Pu Zhao, Wan Huang, Fei Song, Bo Wu and Hong‐Yong Cui and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and SHILAP Revista de lepidopterología.

In The Last Decade

Jian‐Li Jiang

86 papers receiving 3.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

New insights into the roles of CHOP-induced apoptosis in ER stress

2014 438 citations Juan Tang, Jian‐Li Jiang et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Jian‐Li Jiang China	35	2.3k	927	621	533	487	91	3.7k
Jing Pan United States	37	2.5k 1.1×	542 0.6×	739 1.2×	915 1.7×	400 0.8×	142	4.4k
Aideen Long Ireland	32	1.6k 0.7×	788 0.9×	770 1.2×	300 0.6×	454 0.9×	95	3.6k
Youngmi Kim South Korea	36	2.4k 1.0×	736 0.8×	838 1.3×	1.0k 1.9×	492 1.0×	146	4.8k
Jennifer Zhang United States	32	2.1k 0.9×	667 0.7×	624 1.0×	708 1.3×	378 0.8×	120	3.9k
James H. Segars United States	53	2.2k 0.9×	985 1.1×	370 0.6×	283 0.5×	351 0.7×	282	9.0k
Peng Guo China	42	3.3k 1.4×	1000 1.1×	1.0k 1.6×	1.2k 2.3×	375 0.8×	144	5.7k
Nick Pullen United States	31	2.6k 1.1×	741 0.8×	546 0.9×	242 0.5×	351 0.7×	96	4.6k
Yunmei Wang United States	29	3.0k 1.3×	803 0.9×	1.6k 2.6×	576 1.1×	502 1.0×	67	5.0k
Koji Nakamura Japan	38	2.3k 1.0×	620 0.7×	623 1.0×	870 1.6×	281 0.6×	212	4.9k
Pu Zhang China	36	3.1k 1.3×	1.5k 1.7×	992 1.6×	597 1.1×	359 0.7×	163	6.5k

Countries citing papers authored by Jian‐Li Jiang

Since Specialization

Citations

This map shows the geographic impact of Jian‐Li Jiang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jian‐Li Jiang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jian‐Li Jiang more than expected).

Fields of papers citing papers by Jian‐Li Jiang

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jian‐Li Jiang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jian‐Li Jiang. The network helps show where Jian‐Li Jiang may publish in the future.

Co-authorship network of co-authors of Jian‐Li Jiang

This figure shows the co-authorship network connecting the top 25 collaborators of Jian‐Li Jiang. A scholar is included among the top collaborators of Jian‐Li Jiang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jian‐Li Jiang. Jian‐Li Jiang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Qian, Meirui, Xue Liang, Jing Lin, et al.. (2024). Targeting autophagy in HCC treatment: exploiting the CD147 internalization pathway. Cell Communication and Signaling. 22(1). 583–583.

Wang, Bo, Yang Wang, Ping Chen, et al.. (2024). Hypoxia‐activated ADCC‐enhanced humanized anti‐CD147 antibody for liver cancer imaging and targeted therapy with improved selectivity. SHILAP Revista de lepidopterología. 5(3). e512–e512. 6 indexed citations

Li, Yi‐Ming, et al.. (2023). SMURF2 facilitates ubiquitin-mediated degradation of ID2 to attenuate lung cancer cell proliferation. International Journal of Biological Sciences. 19(11). 3324–3340. 5 indexed citations

Cui, Hong‐Yong, Wei Wei, Xin Fu, et al.. (2022). PDGFA‐associated protein 1 is a novel target of c‐Myc and contributes to colorectal cancer initiation and progression. Cancer Communications. 42(8). 750–767. 16 indexed citations

Zheng, Ming, Yiming Li, Zhenyu Liu, et al.. (2022). Prognostic Landscape of Tumor-Infiltrating T and B Cells in Human Cancer. Frontiers in Immunology. 12. 731329–731329. 11 indexed citations

Qian, Meirui & Jian‐Li Jiang. (2020). COVID-19 and social distancing. Journal of Public Health. 30(1). 259–261. 185 indexed citations

Jin, Jin, Shijie Wang, Jian Cui, et al.. (2019). Hypo-phosphorylated CD147 promotes migration and invasion of hepatocellular carcinoma cells and predicts a poor prognosis. Cellular Oncology. 42(4). 537–554. 17 indexed citations

Qi, Shanshan, Jing Li, Pu Zhao, et al.. (2019). YIPF2 is a novel Rab-GDF that enhances HCC malignant phenotypes by facilitating CD147 endocytic recycle. Cell Death and Disease. 10(6). 462–462. 23 indexed citations

Lin, Jing, Fei Song, Zhenyu Liu, et al.. (2017). MLKL-PITPα signaling-mediated necroptosis contributes to cisplatin-triggered cell death in lung cancer A549 cells. Cancer Letters. 414. 136–146. 45 indexed citations

10.

Wu, Bo, Jian Cui, Xiang-Min Yang, et al.. (2017). Cytoplasmic fragment of CD147 generated by regulated intramembrane proteolysis contributes to HCC by promoting autophagy. Cell Death and Disease. 8(7). e2925–e2925. 34 indexed citations

11.

Zhou, Yang, Bo Wu, Jianghua Li, et al.. (2017). Rab22a enhances CD147 recycling and is required for lung cancer cell migration and invasion. Experimental Cell Research. 357(1). 9–16. 30 indexed citations

12.

Li, Jianghua, Wan Huang, Lin Peng, et al.. (2016). N-linked glycosylation at Asn152 on CD147 affects protein folding and stability: promoting tumour metastasis in hepatocellular carcinoma. Scientific Reports. 6(1). 35210–35210. 36 indexed citations

13.

Chen, Ruo, Shijie Wang, Yang Zhang, et al.. (2016). CD147 promotes cell motility via upregulation of p190-B RhoGAP in hepatocellular carcinoma. Cancer Cell International. 16(1). 69–69. 7 indexed citations

14.

Wu, Jiao, et al.. (2014). HAb18G/CD147 Promotes Radioresistance in Hepatocellular Carcinoma Cells: A Potential Role for Integrin β1 Signaling. Molecular Cancer Therapeutics. 14(2). 553–563. 48 indexed citations

15.

Li, Hongwei, Xiang-Min Yang, Juan Tang, et al.. (2014). Effects of HAb18G/CD147 Knockout on Hepatocellular Carcinoma Cells In Vitro Using a Novel Zinc-Finger Nuclease-Targeted Gene Knockout Approach. Cell Biochemistry and Biophysics. 71(2). 881–890. 6 indexed citations

16.

Jiang, Jian‐Li, et al.. (2014). Intravenous pretreatment with emulsified isoflurane preconditioning protects kidneys against ischemia/reperfusion injury in rats. BMC Anesthesiology. 14(1). 28–28. 16 indexed citations

17.

Cui, Hong‐Yong, Tao Guo, Shijie Wang, et al.. (2012). Dimerization is essential for HAb18G/CD147 promoting tumor invasion via MAPK pathway. Biochemical and Biophysical Research Communications. 419(3). 517–522. 38 indexed citations

18.

Zhao, Pu, Wei Zhang, Juan Tang, et al.. (2009). Annexin II promotes invasion and migration of human hepatocellular carcinoma cells in vitro via its interaction with HAb18G/CD147. Cancer Science. 101(2). 387–395. 72 indexed citations

19.

Tang, Juan, et al.. (2008). Overexpression of HAb18G/CD147 promotes invasion and metastasis via α3β1 integrin mediated FAK-paxillin and FAK-PI3K-Ca2+ pathways. Cellular and Molecular Life Sciences. 65(18). 2933–2942. 82 indexed citations

20.

Tang, Juan, Hongwei Zhou, Jian‐Li Jiang, et al.. (2007). BetaIg-h3 is involved in the HAb18G/CD147-mediated metastasis process in human hepatoma cells.. PubMed. 232(3). 344–52. 35 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact